+100%-
+100%-
 Ampligen is a breakthrough for some people with ME/CFS - yet it is still not available.

Ampligen is a breakthrough for some people with ME/CFS – yet it is still not available.

With a UK trial for Rituximab at least temporarily in doubt, let’s turn the focus to Ampligen – a drug that is potentially one trial away from being approved for ME/CFS.  Ampligen is still the only drug that’s been able to move the needle on exercise in ME/CFS.

With NIH director Collins making noises about a possible Ampligen trial and a new review paper out, it’s time to make the case for Ampligen.

Check out a Simmaron Research Foundation sponsored blog:

 

Health Rising’s Quickie Summer Donation Drive is On!

Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can. 

Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000. 

 Find out more here.

 

Health Rising’s Quickie Summer Donation Drive is On!

Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can. 

Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000. 

 Find out more here.

Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest

Share This